Viewing Study NCT01924169


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-01-20 @ 9:50 PM
Study NCT ID: NCT01924169
Status: TERMINATED
Last Update Posted: 2018-09-20
First Post: 2013-08-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Organization: